Here, we review some recent advances in our understanding of the immunological changes associated with chemotherapy, discuss progress in combining chemotherapy with checkpoint blockade, and comment on the difficulties encountered in translating promising preclinical data into successful treatments for cancer ...
A patient with metastatic breast cancer came to the trial after receiving multiple treatments, including several chemotherapy and hormonal treatments, which had not stopped her cancer from progressing. To treat her, the researchers sequenced DNA and RNA from one of her tumors, as well as normal ti...
Demography, cancer-related information, and inflammation were evaluated for their associations with chemotherapy, targeted therapy, and immunotherapy. Inflammation was measured by C-reactive protein, albumin, and neutrophil to lymphocyte ratio. ... DC Mcfarland - 《General Hospital Psychiatry》 被引量:...
Cancer immunotherapy has revolutionized the treatment of cancer. Compared to chemotherapy and other drugs that directly kill tumor cells, cancer immunotherapy can stimulate and/or promote the immune system in the body to indirectly attack and kill tumor cells, with the goal of improving anti-tumor ...
The use of immunotherapy in tandem with chemotherapy is the future of treating patients with NSCLC, according to expert Catherine Shu, MD. Immunotherapy has changed how oncology professionals can approach treatment options for patients with lung cancer, and in the case of patients with rese...
Some monoclonal antibodies can have chemotherapy drugs or radioactive substances attached to them and can help stop the growth of cancer cells. These molecules treat many different types of cancer. Researchers are studying their possibilities for treating many more. ...
Haozhe Huang, Jingjing Sun, LinXinTian Zhang, Runzi Sun, Daniel J. Bain, James F. Conway, Binfeng Lu, Song Li.Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy.Nature Nanotechnology, 2022; DOI:10.1038/s41565-022-01266-2...
Explore BPS Bioscience’s cancer and immunotherapy solutions for cutting-edge research. Discover products and services designed to advance your studies in cancer treatment and immune system modulation.
Conjugate at 2'-O position demonstrates both antitumor activity and synergism bewteen the effects of muramyl dipeptide and paclitaxel for activating mouse peritoneal macrophages. 展开 关键词: Muramyl dipeptide Paclitaxel Chemical conjugation Synergism Immunotherapy Chemotherapy Cancer ...
Immunotherapy is a new type of tumor treatment after surgery, radiotherapy and chemotherapy, and can be used to manage and destroy tumor cells through activating or strengthening the immune response. Immunotherapy has the benefits of a low recurrence rate and high specificity compared to traditional ...